10% of all cancer incidents. Leukemia, lymphoma and myeloma

Under the auspice of CBRC, the Varda and Boaz Dotan Research Center in Hemato-Oncology was established in 2014. This  unique research center is entirely devoted to deepen the understanding of hemato-oncological malignancies and the future development of measures for prevention, diagnosis, and cure of these cancers. Over 20 different research teams are dedicated to find cure to the various types of leukemia, lymphoma or myeloma that account for 10% of all cancer incidents.


The center provided research grants to 36 research groups which resulted in numerous papers and presentations in international conferences. 


Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>
Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
UI/UX Basch_Interactive